Share of novel drug approvals meeting user fee goal dates
RecordSTO-6W7HZQ6HFK-V7TZH7ZBNN-5EA5VG
United States · 2024
Share of novel drug approvals meeting user fee goal dates in the United States was 94% in 2024 (FDA).
New drug approvals in United States: every year, the rank and how it is measured
- Publisher
- FDA
- Authority tier
- T1 Official
- Locator
- CDER’s Effectiveness Bringing New Therapies to Market
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
User Fee Goal Performance: In 2024, CDER met or exceeded its Prescription Drug User Fee Act goal date for 47 of the 50 novel drug approvals (94%).
Checked: the figure 94%is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_6W7HZQ6HFKV7TZH7ZBNN5EA5VG
Other formats: MLA, Chicago, BibTeX
- MLA
- U.S. Food and Drug Administration. "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024." 2024, https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_6W7HZQ6HFKV7TZH7ZBNN5EA5VG.
- Chicago
- U.S. Food and Drug Administration. "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024." 2024. https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_6W7HZQ6HFKV7TZH7ZBNN5EA5VG.
- BibTeX
- @misc{fda2024share5ea5vg, author = {{U.S. Food and Drug Administration}}, title = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_6W7HZQ6HFKV7TZH7ZBNN5EA5VG}, note = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- U.S. Food and Drug Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024
- Type
- Press release
- Published
- —
- Locator
- CDER’s Effectiveness Bringing New Therapies to Market
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_6W7HZQ6HFKV7TZH7ZBNN5EA5VG